Clinician-scientist conducting empirical research and knowledge translation to enhance usefulness of child health research aimed to improve health outcomes.
SickKids-led papers co-published in BMJ, JAMA and Lancet journals introduce 30 new protocols and reporting items for paediatric randomized controlled trials, co-developed with youth and family caregivers.
Read the #SKResearch ⬇️
https://t.co/bceJ52fBsi
📄 This JAMA Pediatrics Patient Page describes how new guidance aiming to improve reporting of clinical trials may help young people and parents find information to make the right health care decisions for them.
https://t.co/S6EWReDWZe
The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years.
https://t.co/qCccpoG16G
The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years.
https://t.co/6M3VVNKbvQ
💬 Editor's Note from JAMA Pediatrics Editor in Chief Dimitri A. Christakis, MD, MPH: The new CONSORT-C and SPIRIT-C guidelines mark a pivotal advance in pediatric research by establishing standards that reflect the unique needs of children.
https://t.co/5Zp2S99UBr
📢 New paper alert! The TIDieR-C guideline presents 13 pediatric considerations to support transparent reporting of trial interventions in pediatric trial protocols & reports.
Paper ➡️ https://t.co/eu9voPNJNv
Fillable checklists ➡️ https://t.co/zEHvjTkpMT
Science is not a contest to be won.
It’s a collective pursuit of truth that evolves with evidence - not a debate settled by opinion or the loudest voice.
Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants with a high risk profile for BPD.
Endotracheal instillation of budesonide with surfactant as a carrier is a promising intervention.
https://t.co/8hDGB9iAKl
2024 revision to the Declaration of Helsinki @JAMA_current highlights the importance of completeness & accuracy of study reports + adhere to accepted guidelines for reporting
https://t.co/0KzthD8eh3
Visit our guideline repository at the EQUATOR Network
https://t.co/tyZWLURxZa
📢 Attention Clinical Trialists: We are hiring a post-doc fellow with expertise in rare disease/child health clinical trial methods for RareKids-CAN: a new Canadian Pediatric Rare Disease Clinical Trials and Treatment Network!
➡️ For more info & to apply: https://t.co/ka0ITgxlW5
A few weeks ago the @WHO published new guidance on best practice for clinical trials. It provides really useful considerations for the design and delivery of a quality trial & the wider trials eco-system 1/6
#MethodologyMonday #101
Today is #WorldMentalHealthDay 💙 This year's theme is 'It is Time to Prioritise Mental Health in the Workplace'. On this World Mental Health Day, let's prioritize our mental well-being.
For more information check out the website linked below.
Link: (https://t.co/jSLlYTZ7Jn)
@Maureenchats and @BethPotter4 sharing how they have been learning about how to include people with lived experience in the ‘how’ stage (COMS). Great meeting organised by @GorstSarah from COMET!
It's here! The @WHO guidance for best practices in clinical trials.
Appreciate the "always on, always warm"
trial infrastructure rec which will have game changing impact on our ability to answer clinical questions that matter more efficiently.
Read 👇🏻
https://t.co/UoV3QEKjur
Hot off the press! The #PrismaCosmin reporting guideline is here! Find the reporting checklist and the full publication here: https://t.co/iJi55ZWWOf. Find additional resources to help you use the #ReportingGuideline at https://t.co/XQdYlpP3Ya!
📢📢TWO NEW and #OpenAccess publications in @bmj_latest as a culmination of the SPIRIT|CONSORT-Surrogate project.
CONSORT-Surrogate: https://t.co/ji7584vmXI
SPIRIT-Surrogate: https://t.co/9hp1lag8BL
Please share or RT for awareness
🧵